Catalyst Pharmaceuticals (CPRX): We Are Confident of Firdapse’s Approvability, Says Analyst

Catalyst Pharmaceuticals (NASDAQ:CPRX) is expecting the FDA to rule on its marketing application for Firdapse, a form of 3,4-diaminopyridine used for the treatment of Lambert …

Why Galmed Pharmaceuticals (GLMD) Is a $59 Stock

Galmed Pharmaceuticals (NASDAQ:GLMD) shares are soaring nearly 20% in after-hours trading Wednesday, as the drug maker gets a vote of confidence from Cantor …

Dynavax Technologies Corporation (DVAX) Gains a Cantor Bull on Back of Compelling HBV Opportunity

Analyst initiates a bullish perspective on Dynavax, ascribing a probability of 95% approval for its lead asset.

Snap Inc (SNAP) Gets a Price Target Boost on Meaningful Upside Potential for Monetization Per Minute

Analyst sees higher ad revenue per daily active user growth ahead for Snap and attractive valuation.

Cantor Asserts That Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Loan Amendments Get Rid of Meaningful Overhang on Stock

Analyst says share weakness does not stem from encouraging news, but points to other underlying concerns.

Supernus Pharmaceuticals Inc (SUPN) Investors Are Scared Off by Elimination of Low SPN-810 Dose; Cantor Makes a Bullish Case

Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.

Another Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Divestiture? Cantor Says Women’s Health Franchise Sale Could Drive Share Appreciation

Though Teva shares took a hit upon the news, the analyst sees an upside to expectations in the distance.

Cantor Spotlights Meaningful Opportunity for Nabriva Therapeutics plc – Ordinary Shares (NBRV) in CABP as Stock Goes Through the Roof

Analyst believes impressive Phase 3 data read-out bolsters expectations for lefamulin’s peak sales potential.

Array Biopharma Inc’s (ARRY) BRAF-Mutant Melanoma Combo Treatment Gets a PDUFA Date; Cantor Chimes In

Analyst expected NDA acceptance- but believes the FDA news importantly lowers regulatory risk for ARRY.

Health Insurance Innovations Inc Shares Face the Heat; Cantor Finds Weakness Unfounded

Analyst dismisses negative publicity haunting HIIQ as unjustified extrapolation from past settlements.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts